LUOTAI group treated with LUOTAI with dosage, dosing schedule and duration follows local clinical practice in accordance with the terms of the local marketing authorization: 400mg of LUOTAI injectable lyophilized powder diluted in 250ml of 5% Glucose Solution or 0.9% Normal Saline for included diabetic patients, via slow intravenous infusion, once daily for consecutive 14 days, and followed by 200mg of LUOTAI soft capsules, three times a day for 65 days.

Control group comprises of patients who are not treated with LUOTAI, and follows local clinical practice for ischemic stroke.

Infarction, Anterior Cerebral Artery

Infarction, Middle Cerebral Artery

Ischemic Attack, Transient

Bach Mai Hospital

Phu Tho General Hospital

103 Military Hospital

An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam

A Non-interventional, Controlled, Open-label, Observational Registry Study to Investigate the Safety and Effectiveness of LUOTAI (Panax Notoginseng) Injectable and Soft Capsules in Patients With Acute Ischemic Stroke in Vietnam

Modified Rankin Scale (mRS) is an overall functional outcome measure, measuring stroke defect. Answer the test questions for 5-10 minutes. The score range is 7 points with a score of 0 for the absence of sequelae and the worst possible score is 6.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
- Moderate disability. Requires some help, but able to walk unassisted.
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
- Dead. Primary Efficacy Endpoint defined as "Categorical shift in mRS score at 3 months (ordinal logistic regression analysis of the mRS on Day 90)".

Ordinal NIHSS at 3 months after stroke onset

Ordinal MoCA at 3 months after stroke onset

Proportion of patients with excellent recovery and functional dependence at 3 months after stroke onset (mRC=0 or 1)

KPC Pharmaceuticals, Inc

Ginsenoside :
Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group

Dietary fiber fill manufactured to mimic Ginsenoside tablet

Metabolic Syndrome

Ginsenoside

Dietary fiber fill

The goal of Korean ginsengsociety is to help elevate the level of ginseng science in both theory and practice by providing technical information to the ginseng industry, providing ginseng-related education to the community.

Bundang CHA Hospital

Ginsenoside Improve Metabolic Syndrome

Effects of Ginsenoside Supplementation on Insulin Resistance and Cardiometabolic Risk Factors in Men With Metabolic Syndrome: a Randomized Controlled Trial.

Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight

insulin ,cortisol, testosterone, somatomedin-c and DHEAS

Dong-Hyuk Jung

Assistant professor, Family medicine

CHA University

The Korean Society of Ginseng

four, 250mg tablets daily 5-14 days prior to surgery

ginsenoside m 5/inflammation

An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam

Ginsenoside Improve Metabolic Syndrome

A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer

Baz done ki pi konplè remèd fèy medsin te apiye nan syans